Multi-Institutional Experience of Stereotactic Ablative Radiation Therapy for Stage I Small Cell Lung Cancer
Vivek Verma(Christ University), Steven H. Lin(The University of Texas MD Anderson Cancer Center), Roy H. Decker(Yale University), P.A. Paximadis(Wayne State University), Matthew M. Harkenrider(Loyola University Chicago), John M. Stahl(Yale University), Minesh P. Mehta(Columbia University), Megan E. Daly(University of California Davis Medical Center), Christopher L. Hallemeier(Mayo Clinic in Arizona), Henning Willers(Massachusetts General Hospital), Russell K. Hales(Johns Hopkins University), S. Gajjar(Baylor College of Medicine), Jing Zeng(Fred Hutch Cancer Center), Gregory M.M. Videtic(Cleveland Clinic), Chirag Shah(Cleveland Clinic), Charles B. Simone(New York Proton Center), Salma K. Jabbour(Rutgers, The State University of New Jersey), Pamela K. Allen(The University of Texas MD Anderson Cancer Center), Joshua M. Walker(Oregon Health & Science University), Steve Braunstein(University of California, San Francisco), Chance Matthiesen(Oklahoma State University Oklahoma City), Bryan G. Allen(University of Iowa Hospitals and Clinics), Thomas J. Dilling(Moffitt Cancer Center), Fen Wang(Central South University), Albert Attia(Vanderbilt University), E.M. Nichols(University of Maryland, Baltimore), Tithi Biswas(University of Rochester Medical Center), Weining Zhen(Susan Thompson Buffett Foundation), Percy Lee(University of California, Los Angeles)
International Journal of Radiation Oncology*Biology*Physics
November 2, 2016
Cited by 91
Related Papers
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
|The Lancet|2004|2.4k
Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases
|Journal of Clinical Oncology|2011|1.4k
Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|1.4k